Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,160 | -11,911 | -9,493 | -6,903 | -2,743 |
| Depreciation Amortization | 17 | 68 | 51 | 34 | 18 |
| Accounts payable and accrued liabilities | -3 | 129 | 417 | 363 | 270 |
| Other Working Capital | -302 | 635 | 421 | 686 | 448 |
| Other Operating Activity | 805 | 2,842 | 1,804 | 1,171 | 555 |
| Operating Cash Flow | $-1,643 | $-8,237 | $-6,800 | $-4,649 | $-1,452 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 2,101 | 2,101 | 2,101 | 2,101 |
| Investing Cash Flow | $N/A | $2,101 | $2,101 | $2,101 | $2,101 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,898 | N/A | 0 | N/A | N/A |
| Financing Cash Flow | $1,898 | $N/A | $0 | $N/A | $N/A |
| Beginning Cash Position | 10,479 | 16,615 | 16,615 | 16,615 | 16,615 |
| End Cash Position | 10,734 | 10,479 | 11,916 | 14,067 | 17,264 |
| Net Cash Flow | $255 | $-6,136 | $-4,699 | $-2,548 | $649 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,643 | -8,237 | -6,800 | -4,649 | -1,452 |
| Free Cash Flow | -1,643 | -8,237 | -6,800 | -4,649 | -1,452 |